Found: 219
Select item for more details and to access through your institution.
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 2, p. 182, doi. 10.1002/gcc.20732
- By:
- Publication type:
- Article
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1434, doi. 10.1002/ajh.27333
- By:
- Publication type:
- Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
- By:
- Publication type:
- Article
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. 1383, doi. 10.1002/ajh.26997
- By:
- Publication type:
- Article
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
- By:
- Publication type:
- Article
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E91, doi. 10.1002/ajh.26858
- By:
- Publication type:
- Article
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1599, doi. 10.1002/ajh.26731
- By:
- Publication type:
- Article
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
- By:
- Publication type:
- Article
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1443, doi. 10.1002/ajh.26694
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 885, doi. 10.1002/ajh.26572
- By:
- Publication type:
- Article
Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
- By:
- Publication type:
- Article
Dr. Elihu H. Estey (1946–2021).
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 166, doi. 10.1002/ajh.26415
- By:
- Publication type:
- Article
Prediction of early (4‐week) mortality in acute myeloid leukemia with intensive chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 68, doi. 10.1002/ajh.26395
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E275, doi. 10.1002/ajh.26202
- By:
- Publication type:
- Article
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E246, doi. 10.1002/ajh.26182
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
GATA3 rs3824662A allele in B‐cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E71, doi. 10.1002/ajh.26065
- By:
- Publication type:
- Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
- By:
- Publication type:
- Article
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E326, doi. 10.1002/ajh.25991
- By:
- Publication type:
- Article
The clinical impact of time to response in de novo accelerated‐phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1127, doi. 10.1002/ajh.25907
- By:
- Publication type:
- Article
Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 734, doi. 10.1002/ajh.25784
- By:
- Publication type:
- Article
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 612, doi. 10.1002/ajh.25769
- By:
- Publication type:
- Article
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 144, doi. 10.1002/ajh.25671
- By:
- Publication type:
- Article
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 984, doi. 10.1002/ajh.25553
- By:
- Publication type:
- Article
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E188, doi. 10.1002/ajh.25490
- By:
- Publication type:
- Article
Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. E357, doi. 10.1002/ajh.25240
- By:
- Publication type:
- Article
Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1245, doi. 10.1002/ajh.25234
- By:
- Publication type:
- Article
Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1136, doi. 10.1002/ajh.25198
- By:
- Publication type:
- Article
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 277, doi. 10.1002/ajh.24972
- By:
- Publication type:
- Article
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 84, doi. 10.1002/ajh.24943
- By:
- Publication type:
- Article
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1295, doi. 10.1002/ajh.24897
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E595, doi. 10.1002/ajh.24833
- By:
- Publication type:
- Article
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 924, doi. 10.1002/ajh.24799
- By:
- Publication type:
- Article
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 599, doi. 10.1002/ajh.24735
- By:
- Publication type:
- Article
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E114, doi. 10.1002/ajh.24720
- By:
- Publication type:
- Article
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 279, doi. 10.1002/ajh.24629
- By:
- Publication type:
- Article
Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. E14, doi. 10.1002/ajh.24597
- By:
- Publication type:
- Article
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. E3, doi. 10.1002/ajh.24579
- By:
- Publication type:
- Article
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1221, doi. 10.1002/ajh.24500
- By:
- Publication type:
- Article
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 819, doi. 10.1002/ajh.24419
- By:
- Publication type:
- Article
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia ( AML) and myelodysplastic syndrome ( MDS).
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 227, doi. 10.1002/ajh.24252
- By:
- Publication type:
- Article
Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 769, doi. 10.1002/ajh.24074
- By:
- Publication type:
- Article
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 8, p. 732, doi. 10.1002/ajh.24072
- By:
- Publication type:
- Article
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 3, p. 193, doi. 10.1002/ajh.23901
- By:
- Publication type:
- Article
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone ( MOp AD) in patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 120, doi. 10.1002/ajh.23886
- By:
- Publication type:
- Article
Improving outcomes for patients with acute myeloid leukemia in first relapse: A single center experience.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 1, p. 27, doi. 10.1002/ajh.23858
- By:
- Publication type:
- Article